5 Best Biotech Stocks To Buy Under $20

Page 5 of 5

1. Roivant Sciences Ltd (NASDAQ:ROIV)

Price: $10.70

Nr of Hedge Funds Shareholders: 55

Last but not least, Roivant Sciences Ltd (NASDAQ:ROIV) leads the list of best biotech stocks to buy under $20, with 55 funds tracked by Insider Monkey having disclosed long positions in the company as of the end of December, up by 11 over the quarter. Among these investors, Daniel Gold’s QVT Financial is the top shareholder with a $1.26 billion position containing 112.54 million shares. Other renowned investors bullish on Roivant Sciences Ltd (NASDAQ:ROIV) are Andreas Halvorsen’s Viking Global, Julian Baker and Felix Baker’s Baker Bros. Advisors, and David Rosen’s Rubric Capital Management.

Roivant Sciences Ltd (NASDAQ:ROIV) was founded by former Republican Presidential candidate Vivek Ramaswamy. The company is developing drugs and builds subsidiary biotech companies, such as Immunovant and Dermavant. For the last reported quarter, Roivant Sciences Ltd (NASDAQ:ROIV) posted a net loss of $0.21 per share, beating the consensus estimate of $0.27, and its revenue of $37.14 million was also higher than expected. 

Page 5 of 5